Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernard Chevalier

Showing results (121-130 of 227) with videos related to

Pageof 23
Sort By:
JAMA Cardiology|January 6, 2021
Assessing the Risks of Bleeding vs Thrombotic Events in Patients at High Bleeding Risk After Coronary Stent Implantation: The ARC-High Bleeding Risk Trade-off ModelPhilip Urban, John Gregson, Ruth Owen, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|November 3, 2017
Four-year follow-up of the randomised comparison between an everolimus-eluting bioresorbable scaffold and an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II Trial)Bernard Chevalier, Angel Cequier, Dariusz Dudek, et al.
JACC. Cardiovascular Interventions|November 24, 2018
1-Year Outcomes With the Evolut R Self-Expanding Transcatheter Aortic Valve: From the International FORWARD StudyGanesh Manoharan, Nicolas M Van Mieghem, Stephan Windecker, et al.
The Canadian Journal of Cardiology|December 31, 2016
Comparison of Systematic Predilation, Selective Predilation, and Direct Transcatheter Aortic Valve Implantation With the SAPIEN S3 ValveMarco Spaziano, Fadi Sawaya, Bernard Chevalier, et al.
Archives of Cardiovascular Diseases|May 19, 2020
Evaluation of length of stay after transfemoral transcatheter aortic valve implantation with SAPIEN 3 prosthesis: A French multicentre prospective observational trialEric Durand, Hervé Le Breton, Thierry Lefevre, et al.
JACC. Cardiovascular Interventions|December 27, 2016
Efficacy and Safety of the Absorb Everolimus-Eluting Bioresorbable Scaffold for Treatment of Patients With Diabetes Mellitus: Results of the Absorb Diabetic SubstudyDean J Kereiakes, Stephen G Ellis, Takeshi Kimura, et al.
JACC. Cardiovascular Interventions|May 25, 2019
TAVR for Failed Surgical Aortic Bioprostheses Using a Self-Expanding Device: 1-Year Results From the Prospective VIVA Postmarket StudyDidier Tchétché, Bernard Chevalier, David Holzhey, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 9, 2021
Optimal dual antiplatelet therapy duration for bioresorbable scaffolds: an individual patient data pooled analysis of the ABSORB trialsLorenzo Azzalini, Stephen G Ellis, Dean J Kereiakes, et al.
JACC. Cardiovascular Interventions|November 26, 2016
Direct Comparison of Feasibility and Safety of Transfemoral Versus Transaortic Versus Transapical Transcatheter Aortic Valve ReplacementTakahide Arai, Mauro Romano, Thierry Lefèvre, et al.
The American Journal of Cardiology|December 31, 2020
Transcatheter Aortic Valve Implantation for Failed Surgical Aortic Bioprostheses Using a Self-Expanding Device (from the Prospective VIVA Post Market Study)Ran Kornowski, Bernard Chevalier, Jean-Philippe Verhoye, et al.
Pageof 23

Showing results (121-130 of 227) with videos related to

Sort By:
Pageof 23
JAMA Cardiology|January 6, 2021
Assessing the Risks of Bleeding vs Thrombotic Events in Patients at High Bleeding Risk After Coronary Stent Implantation: The ARC-High Bleeding Risk Trade-off ModelPhilip Urban, John Gregson, Ruth Owen, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|November 3, 2017
Four-year follow-up of the randomised comparison between an everolimus-eluting bioresorbable scaffold and an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II Trial)Bernard Chevalier, Angel Cequier, Dariusz Dudek, et al.
JACC. Cardiovascular Interventions|November 24, 2018
1-Year Outcomes With the Evolut R Self-Expanding Transcatheter Aortic Valve: From the International FORWARD StudyGanesh Manoharan, Nicolas M Van Mieghem, Stephan Windecker, et al.
The Canadian Journal of Cardiology|December 31, 2016
Comparison of Systematic Predilation, Selective Predilation, and Direct Transcatheter Aortic Valve Implantation With the SAPIEN S3 ValveMarco Spaziano, Fadi Sawaya, Bernard Chevalier, et al.
Archives of Cardiovascular Diseases|May 19, 2020
Evaluation of length of stay after transfemoral transcatheter aortic valve implantation with SAPIEN 3 prosthesis: A French multicentre prospective observational trialEric Durand, Hervé Le Breton, Thierry Lefevre, et al.
JACC. Cardiovascular Interventions|December 27, 2016
Efficacy and Safety of the Absorb Everolimus-Eluting Bioresorbable Scaffold for Treatment of Patients With Diabetes Mellitus: Results of the Absorb Diabetic SubstudyDean J Kereiakes, Stephen G Ellis, Takeshi Kimura, et al.
JACC. Cardiovascular Interventions|May 25, 2019
TAVR for Failed Surgical Aortic Bioprostheses Using a Self-Expanding Device: 1-Year Results From the Prospective VIVA Postmarket StudyDidier Tchétché, Bernard Chevalier, David Holzhey, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 9, 2021
Optimal dual antiplatelet therapy duration for bioresorbable scaffolds: an individual patient data pooled analysis of the ABSORB trialsLorenzo Azzalini, Stephen G Ellis, Dean J Kereiakes, et al.
JACC. Cardiovascular Interventions|November 26, 2016
Direct Comparison of Feasibility and Safety of Transfemoral Versus Transaortic Versus Transapical Transcatheter Aortic Valve ReplacementTakahide Arai, Mauro Romano, Thierry Lefèvre, et al.
The American Journal of Cardiology|December 31, 2020
Transcatheter Aortic Valve Implantation for Failed Surgical Aortic Bioprostheses Using a Self-Expanding Device (from the Prospective VIVA Post Market Study)Ran Kornowski, Bernard Chevalier, Jean-Philippe Verhoye, et al.
Pageof 23